At ERT, we have only one focus - delivering reliable results for our clients to bring safe drugs to market faster.
For nearly 40 years, ERT has been at the forefront of providing comprehensive Cardiac Safety Solutions that are vital to our clients' drug safety and testing efforts. We understand that only the most accurate and regulatory-compliant data can ensure reliable, quality outcomes. At ERT, we work diligently to provide thorough execution, driving by our collaborative process and proprietary Project Assurance methodology - all to bring safe drugs to market faster.
Our experience spans:
- More than 5,000 studies and 605,000 subjects/patients
- Trials in more than 95 countries, over six continents
- Single-center, as well as global, multicenter trials
- U.S. and European logistics capabilities for a truly international reach
- Over 1,000 studies and more than 22,000 investigation sites at any time
- Greater than 160 Thorough QT/QTc Trials (TQT) conducted
